DrugCard
PrivateLast Round
Seed
Aug 22, 2023
Total Funding Raised
$288,000
Momentum
Top 50%
of companies Caplight tracks
Company Overview
DrugCard is a health tech company that provides an AI-powered pharmacovigilance platform for automated medical literature screening and drug safety monitoring.
Sector
Healthcare & Life Sciences
Verticals
Compliance & Risk, Medical AI, RegTech, Vertical SaaS
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
DrugCard Comparables
Compare DrugCard with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| biologit | 91% | |
| PubHive Ltd. | 86% | |
| Datafoundry | 85% |
DrugCard Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Aug 22, 2023 | ||||
| Seed | Dec 9, 2021 |
Key People
Founding team and executive leadership
DrugCard Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Demium Capital | Seed |
| New Nordic Venture | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 19, 2026
Monthly visitors increased 51% MoM.
- May 22, 2026
Grew 26% QoQ, from 19 to 24 employees.
DrugCard Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about DrugCard's valuation, stock price, and market status.
Is DrugCard a public or private company?
DrugCard is a private company.
What is the current stock price of DrugCard?
DrugCard is a private company with no public stock price. No recent secondary market data is available.
How much is DrugCard worth (valuation)?
Valuation information for DrugCard is not publicly available.
Can I buy DrugCard stock?
DrugCard shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was DrugCard's last funding round?
DrugCard's most recent funding round was Seed on August 22, 2023.
Who are the main investors in DrugCard?
Key investors in DrugCard include New Nordic Venture.
Will DrugCard IPO soon?
No public IPO plans have been announced for DrugCard.
How can I track DrugCard secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor DrugCard's secondary market activity and sign up for updates.